Infant Bacterial Therapeutics Reports No FDA Filing Objections at Pre-BLA Meeting

The company said no Refusal to File issues were raised at its October 29 FDA pre-BLA meeting for IBP-9414. It expects formal meeting minutes by the end of November and is continuing work toward BLA submission.